In the rapidly changing treatment environment for inherited bleeding disorders, it can be difficult to keep up to date with all the information from clinical trials and updates on licenced therapies. The Irish Haemophilia Society have teamed up with the Canadian Hemophilia Society to produce a short summary document on major developments in novel therapies. The content is based on published data and congress presentations and abstracts. The plan is to produce this publication twice per year. Issue 1 of 2026 is below.

• Key Developments in Novel Therapies for Bleeding Disorders – Volume 1, Issue 1, 2026